Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 173

Sort by

Sort Order Select

Journal Articles

Developing artificial intelligence-based transcriptomic signature for the diagnosis of dark zone lymphoma in patients without MYC gene rearrangement

Andrew Ip, Maher Albitar, Hong Zhang, Sally Agersborg, Adam Albitar, Ahmad Charifa, Andrew Pecora, David Siegel, Lori Leslie, Andre Goy, Tatyana Feldman

Blood (2025) 146 (Supplement 1): 3525.

https://doi.org/10.1182/blood-2025-3525

Published: 2025

Journal Articles

Integrative clinical and molecular analysis of outcome in elderly African ancestry Acute Myeloid Leukemia

Blood (2025) 146 (Supplement 1): 1733.

https://doi.org/10.1182/blood-2025-1733

Published: 2025

Journal Articles

AI-derived prediction of response and relapse to venetoclax plus hypomethylating agent based therapy in Acute Myeloid Leukemia

Sarvarinder Gill, Maher Albitar, Jamie Koprivnikar, Katherine Linder, Ayrton Bangolo, Behzad Amoozgar, Lili Zhang, James McCloskey

Blood (2025) 146 (Supplement 1): 1731.

https://doi.org/10.1182/blood-2025-1731

Published: 2025

Journal Articles

Ultra high-risk multiple myeloma with early mortality despite quad-class and BCMA-directed therapies: Clinical and molecular insights

Binod Dhakal, Maria Hintzke, Othman Akhtar, Jamila Mammadova, Adetola Kassim, Marcelo Pasquini, Meera Mohan, Ravi Kishore Narra, Sabarinath Radhakrishnan, Fumou Sun, Anita D'Souza, Maher Albitar, Bhagirathbhai Dholaria

Blood (2025) 146 (Supplement 1): 2240.

https://doi.org/10.1182/blood-2025-2240

Published: 2025

Journal Articles

Liquid-biopsy mutation landscape and its concordance with skin biopsies in cutaneous T-cell lymphoma

Yoni Sacknovitz, Maher Albitar, Sara Suhl, Alexander Kaminsky, Brigit Lapolla, Joshua Kent, Maggie Zhou, Seda Tolu, Alejandro Gru, Barbara Pro, Tatyana Feldman, Larisa Geskin

Blood (2025) 146 (Supplement 1): 561.

https://doi.org/10.1182/blood-2025-561

Published: 2025

Journal Articles

Real-world validation of the molecular prognostic risk signature in acute myeloid leukemia treated with hypomethylating agents plus BCL-2 inhibitor.

Jonathan Andreadakis, Olivia Wilkins, Alexander Shkembi, Amy Wu, John Basile, Anna Krzeczowska, Alexandra Thalberg, Linda Linderbeck, Nidia Zapata, Suzane Silbert, Marci O'Driscoll, Anne Renteria, Maher Albitar, Lacey Williams, Jason Salemi, Amy Alman, Tiphaine Martin, David Swoboda, Gustavo Rivero

Blood (2025) 146 (Supplement 1): 3413.

https://doi.org/10.1182/blood-2025-3413

Published: 2025

Journal Articles

Somatic mutations and clinical outcomes in primary central nervous system lymphoma among hispanic and non-hispanic patients: A study from the University of California hematologic malignancies consortium (UCHMC)

Haifaa Abdulhaq, Omar Mahmood, nathan Futoran, Sani Bukari, Calvin Chen, Joseph Tuscano, Aaron Tsumura, Tamer Othman, Elizabeth Brem, Chenchen Niu, Benjamin Heyman, Michelle Don, Azra Borogovac, Matthew Wieduwilt, Maher Albitar

Blood (2025) 146 (Supplement 1): 1755.

https://doi.org/10.1182/blood-2025-1755

Published: 2025

Journal Articles

B- and T-cell clonality using peripheral blood cell-free RNA (cfRNA) in liquid biopsy

Adam Albitar, Alfonso Lam, Sally Agersborg, Ahmad Charifa, Pooja Phull, Noa Biran, David Vesole, Harsh Parmar, Andrew Pecora, Andrew Ip, Andre Goy, David Siegel, Maher Albitar

Blood (2025) 146 (Supplement 1): 1754.

https://doi.org/10.1182/blood-2025-1754

Published: 2025

Journal Articles

Maturing progenitor-like immunophenotypic cluster and megakaryocytic repopulating ability predict measurable residual disease in Acute Myeloid Leukemia

Olivia Wilkins, Jonathan Andreadakis, Alexander Shkembi, Amy Wu, John Basile, Anna Krzeczowska, Alexandra Thalberg, Linda Linderbeck, Nidia Zapata, Marci O'Driscoll, Suzane Silbert, Tiphaine Martin, Anne Renteria, Maher Albitar, Lacey Williams, Jason Salemi, Amy Alman, David Swoboda, Gustavo Rivero

Blood (2025) 146 (Supplement 1): 7049.

https://doi.org/10.1182/blood-2025-7049

Published: 2025

Journal Articles

Developing transcriptomic signature for IDH1 and IDH2 acute leukemia and the demonstration of high prevalence of these signatures in mutation-negative leukemia

Maher Albitar, Hong Zhang, Gustavo Rivero, David Swoboda, Sally Agersborg, Adam Albitar, Ahmad Charifa, Andrew Ip, Andre Goy, Andrew Pecora, David Siegel, Kelly West Fitzpatrick, Katherine Linder, Jamie Koprivnikar, James McCloskey

Blood (2025) 146 (Supplement 1): 5251.

https://doi.org/10.1182/blood-2025-5251

Published: 2025

Journal Articles

Developing artificial intelligence-based transcriptomic signature for selecting patients with HOXA-MEIS1 pathway abnormalities for the treatment with menin inhibitors

Blood (2025) 146 (Supplement 1): 3471.

https://doi.org/10.1182/blood-2025-3471

Published: 2025

Journal Articles

Bone marrow microenvironment overlap between vexas and myelodysplastic syndrome demonstrated by targeted transcriptomic and artificial intelligence

Maher Albitar, Sally Agersborg, Hong Zhang, Adam Albitar, Ahmad Charifa, Andrew Pecora, David Siegel, Andre Goy, Jamie Koprivnikar, James McCloskey, Katherine Linder

Blood (2025) 146 (Supplement 1): 5611.

https://doi.org/10.1182/blood-2025-5611

Published: 2025

Journal Articles

Glucose-6-phosphatase dehydrogenase [G6PD] serum level predicts acute monocytic leukemia differentiation.

Alexander Shkembi, Jonathan Andreadakis, Olivia Wilkins, Amy Wu, John Basile, Anne Renteria, Anna Krzeczowska, David Swoboda, Alexandra Thalberg, Linda Linderbeck, Nidia Zapata, Maher Albitar, Lacey Williams, Gustavo Rivero

Blood (2025) 146 (Supplement 1): 6902.

https://doi.org/10.1182/blood-2025-6902

Published: 2025

Journal Articles

Molecular profiling and kinetics of circulating multiple myeloma cells (CMMCs) predict resistance to bispecific antibodies (BsAbs) in relapsed and/or refractory multiple myeloma (RRMM)

Blood (2025) 146 (Supplement 1): 4012.

https://doi.org/10.1182/blood-2025-4012

Published: 2025

Journal Articles

Integrated cell-free DNA and RNA sequencing recapitulates bone marrow genomic and transcriptomic alterations in multiple myeloma

Blood (2025) 146 (Supplement 1): 7483.

https://doi.org/10.1182/blood-2025-7483

Published: 2025

Journal Articles

Clonotype-Naïve Detection of Clonality in Patients Suspected of Having Multiple Myeloma or Monoclonal Gammopathy Using Peripheral Blood Cell-Free RNA (cfRNA)

Maher Albitar, Hong Zhang, Sally Agersborg, Ahmad Charifa, Pooja Phull, Noa Biran, David H. Vesole, Harsh Parmar, Andrew L Pecora, Andrew Ip, Andre Goy, David S. Siegel

Blood (2024) 144 (Supplement 1): 1946.

https://doi.org/10.1182/blood-2024-201810

Published: 2024

Journal Articles

Parallel Immunotranscriptomic and Immunohistochemistry Enhance Cluster Discrimination in Acute Myelogenous Leukemia

Olivia Wilkins, Munther Hammad, Megan Clyne, Audrey Huelskamp, Hafsa Bhatty, Ali Firozvi, Alexandra Thalberg, Lacey Scott Williams, Anne S. S. Renteria, Maher Albitar, Gustavo A. Rivero

Blood (2024) 144 (Supplement 1): 6155.

https://doi.org/10.1182/blood-2024-211411

Published: 2024

Journal Articles

Immune and Myeloid Differentiation Shape Transcriptome to Discriminate Evolutionary Stages of Cellular Transformation

Lacey Scott Williams, Anne S. S. Renteria, Maher Albitar, Gustavo A. Rivero

Blood (2024) 144 (Supplement 1): 2923.

https://doi.org/10.1182/blood-2024-211159

Published: 2024

Journal Articles

Identifying Clinical and Deregulated Genomic Pathways for Phenotypic Leukostasis in Newly Diagnosed Acute Myelogenous Leukemia

Rachel Zemel, Vincent Cendan, Erika Foerst, Lacey Scott Williams, Hafsa Bhatty, Maher Albitar, Anne S. S. Renteria, Gustavo A. Rivero

Blood (2024) 144 (Supplement 1): 6113.

https://doi.org/10.1182/blood-2024-208696

Published: 2024

Journal Articles

Clearance of Circulating Multiple Myeloma Cells to Assess Early Response to Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma

Blood (2024) 144 (Supplement 1): 4687.

https://doi.org/10.1182/blood-2024-209181

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Developing artificial intelligence-based transcriptomic signature for the diagnosis of dark zone lymphoma in patients without MYC gene rearrangement

Integrative clinical and molecular analysis of outcome in elderly African ancestry Acute Myeloid Leukemia

AI-derived prediction of response and relapse to venetoclax plus hypomethylating agent based therapy in Acute Myeloid Leukemia

Ultra high-risk multiple myeloma with early mortality despite quad-class and BCMA-directed therapies: Clinical and molecular insights

Liquid-biopsy mutation landscape and its concordance with skin biopsies in cutaneous T-cell lymphoma

Real-world validation of the molecular prognostic risk signature in acute myeloid leukemia treated with hypomethylating agents plus BCL-2 inhibitor.

Somatic mutations and clinical outcomes in primary central nervous system lymphoma among hispanic and non-hispanic patients: A study from the University of California hematologic malignancies consortium (UCHMC)

B- and T-cell clonality using peripheral blood cell-free RNA (cfRNA) in liquid biopsy

Maturing progenitor-like immunophenotypic cluster and megakaryocytic repopulating ability predict measurable residual disease in Acute Myeloid Leukemia

Developing transcriptomic signature for IDH1 and IDH2 acute leukemia and the demonstration of high prevalence of these signatures in mutation-negative leukemia

Developing artificial intelligence-based transcriptomic signature for selecting patients with HOXA-MEIS1 pathway abnormalities for the treatment with menin inhibitors

Bone marrow microenvironment overlap between vexas and myelodysplastic syndrome demonstrated by targeted transcriptomic and artificial intelligence

Glucose-6-phosphatase dehydrogenase [G6PD] serum level predicts acute monocytic leukemia differentiation.

Molecular profiling and kinetics of circulating multiple myeloma cells (CMMCs) predict resistance to bispecific antibodies (BsAbs) in relapsed and/or refractory multiple myeloma (RRMM)

Integrated cell-free DNA and RNA sequencing recapitulates bone marrow genomic and transcriptomic alterations in multiple myeloma

Clonotype-Naïve Detection of Clonality in Patients Suspected of Having Multiple Myeloma or Monoclonal Gammopathy Using Peripheral Blood Cell-Free RNA (cfRNA)

Parallel Immunotranscriptomic and Immunohistochemistry Enhance Cluster Discrimination in Acute Myelogenous Leukemia

Immune and Myeloid Differentiation Shape Transcriptome to Discriminate Evolutionary Stages of Cellular Transformation

Identifying Clinical and Deregulated Genomic Pathways for Phenotypic Leukostasis in Newly Diagnosed Acute Myelogenous Leukemia

Clearance of Circulating Multiple Myeloma Cells to Assess Early Response to Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only